‘Exercise is good for the brain’ is the kind of sentence that has appeared so often in health coverage that it can feel like settled background noise — true but unexamined, a fact that lives in the category of things everyone already knows.

The more interesting question, and the one researchers have been working toward for some time, is: what actually happens?

Not at the level of outcome statistics — the observation that people who are more physically active show different rates of cognitive decline, different mood profiles, different brain volumes as they age. Those patterns are real and accumulating across large population datasets. The question is about mechanism: what physically occurs between the moment you start moving your legs and the changes that researchers can later measure in brain tissue?

What the past several years of molecular neuroscience have produced is something more specific and more surprising than the general claim deserves. The mechanism appears to begin not in the brain but in skeletal muscle — in the chemistry of contraction — and it involves a cascade of signals that travel from working muscle through the bloodstream to influence the production of new neurons in the hippocampus.

This is the walk-through.

The Signal Begins in Muscle, Not in the Brain

When skeletal muscle contracts repeatedly — as it does during aerobic activity — the biochemistry inside muscle cells changes in ways that extend well beyond the muscle itself. One of the central events is the activation of a protein called PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), which functions as a master regulator of mitochondrial biogenesis and energy metabolism.

PGC-1α activation during exercise does something that was not well understood until relatively recently: it drives the expression of a membrane-bound protein called FNDC5 (fibronectin type III domain-containing protein 5). FNDC5 is then cleaved and secreted into the bloodstream in a soluble form known as irisin — a myokine, meaning a hormone-like signaling molecule released by muscle during activity.

This PGC-1α → FNDC5 → irisin axis is described in a 2026 narrative review by Ersever, published in the European Journal of Translational Myology, which examined evidence on different exercise modalities and their effects on this signaling pathway across the lifespan (Ersever EM; European Journal of Translational Myology; 2026; PMID 42644357). The pathway is not the only signal exercise releases — a 2026 review in the Journal of Molecular Neuroscience by Razazpour and colleagues also describes lactate and insulin-like growth factor 1 (IGF-1) as systemic factors released during physical activity that contribute to what happens next in the brain (Razazpour F et al.; Journal of Molecular Neuroscience; 2026; PMID 42616196).

The convergence of these signals — irisin, lactate, IGF-1 — at the central nervous system represents a form of inter-organ communication that was not well characterized even a decade ago. Muscle, in this picture, is not merely responding to what the brain directs. It is sending signals back.

How Irisin Reaches the Hippocampus and What It Does There

For a signal released into the bloodstream by muscle to influence the brain, it has to cross the blood-brain barrier — the selective system of endothelial cells and transport proteins that regulates what can pass from the circulation into brain tissue. For irisin, evidence suggests that this crossing is possible through multiple routes, including active transport mechanisms.

Once in the brain, irisin — along with the other systemic exercise factors — appears to converge on a region with particular relevance to memory and mood regulation: the hippocampus. The key downstream target is brain-derived neurotrophic factor, or BDNF, and its principal receptor, TrkB (tropomyosin receptor kinase B).

BDNF is a member of the neurotrophin family — proteins that support the survival, growth, and differentiation of neurons. Its role in hippocampal function is well-established: higher BDNF levels are associated with improved memory, better mood regulation, and greater hippocampal volume. What exercise appears to do, through the irisin pathway and the other concurrent signals, is to robustly upregulate hippocampal BDNF and TrkB expression.

The Razazpour review describes this as a ‘master regulatory network’ that, when activated, promotes neuronal survival, synaptogenesis (the formation of new synaptic connections), and adult neurogenesis — the production of new neurons in the hippocampal dentate gyrus (Razazpour F et al.; Journal of Molecular Neuroscience; 2026; PMID 42616196).

What is notable about this pathway is its specificity. The claim is not that exercise increases general brain activity or produces a nonspecific protective effect. The claim is about a defined molecular cascade in a defined brain region, with defined cellular consequences — and it is a claim that can be tested at each step.

New Neurons in the Exercising Brain

Adult hippocampal neurogenesis — the generation of new neurons in the adult brain — was itself contested for much of the last century, with the prevailing assumption being that the brain you were born with was the brain you were stuck with. That view has been substantially revised. The hippocampal dentate gyrus is one of the few regions of the adult brain where new neurons are consistently generated, and exercise appears to be one of the most reliable stimulants of this process.

But not all neurogenesis is equal. A 2026 review by Wang and colleagues, published in Brain Sciences, draws a distinction between increased progenitor proliferation and what they call ‘productive neurogenesis’ — defined by the survival, maturation, appropriate synaptic positioning, and functional integration of newborn neurons (Wang X et al.; Brain Sciences; 2026; PMID 42793376). Their review examines this in the context of stroke recovery, where hippocampal neurogenesis is disrupted — but the mechanistic framework they describe illuminates the exercise pathway as well.

The distinction matters because it addresses a common oversimplification: that generating more new neurons is straightforwardly beneficial. The research picture is more nuanced. New neurons need to integrate into existing circuits, make appropriate connections, and survive long enough to contribute to function. Exercise, in the evidence reviewed, appears to support this full process — shifting the hippocampal environment from what Wang and colleagues describe as a ‘hostile’ to a ‘permissive’ state for productive neurogenesis, through coordinated effects on neuroinflammation, neurovascular integrity, and mitochondrial function.

A hippocampus with better-supported neurogenesis is associated with improved episodic memory — the kind of memory that involves what happened and when — and with mood regulation. Neither of these associations is fully explained by neurogenesis alone, but neurogenesis appears to be a significant contributor.

What Large-Scale Studies Add to the Picture

Molecular pathway research has the advantage of precision and the disadvantage of scope: it tells you about cells, signaling molecules, and specific brain regions under controlled conditions, but it does not directly tell you what happens at the population level when ordinary people live ordinary lives and move in whatever ways their days require.

For that, researchers have turned to large prospective cohort studies — following tens of thousands of people over years, measuring their physical activity with wrist-worn accelerometers, and tracking health outcomes through linked medical records.

A 2026 study by Liu and colleagues, published in the International Journal of Behavioral Nutrition and Physical Activity, did exactly this, and focused on a form of physical activity that does not require a gym: vigorous intermittent lifestyle physical activity, or VILPA (Liu C et al.; International Journal of Behavioral Nutrition and Physical Activity; 2026; PMID 42786495). VILPA refers to brief bursts of vigorous movement embedded in everyday life — climbing stairs quickly, carrying heavy items, walking fast to catch transportation — not structured exercise sessions. Using accelerometer data from UK Biobank participants who described themselves as non-exercisers, the study tracked associations between VILPA and the incidence of several common brain-related outcomes over a median follow-up of approximately eight years.

The results were prospective associations, not demonstrated causal effects. VILPA was associated with lower risk of depression (hazard ratio 0.86, 95% CI 0.75–0.99), dementia (HR 0.72, 95% CI 0.59–0.88), and anxiety (HR 0.80, 95% CI 0.71–0.90) in the cohort (Liu C et al.; International Journal of Behavioral Nutrition and Physical Activity; 2026; PMID 42786495).

Two things about these numbers deserve emphasis. First, the confidence intervals are meaningful: the 95% CI for the depression association, for example, runs from 0.75 to 0.99, which means the range of plausible true effect sizes runs from a 25% risk reduction to essentially no reduction at all. Second, and more importantly, association in an observational cohort study does not establish causation. People who engage in more VILPA differ from those who do not in many other ways — health status, socioeconomic circumstances, other health behaviors — and not all of those differences can be fully controlled for even in a well-designed analysis.

What the Research Does Not Yet Establish

Several important cautions apply to the evidence summarized here.

Both the Razazpour review (2026, Journal of Molecular Neuroscience) and the Ersever review (2026, European Journal of Translational Myology) are narrative reviews — syntheses of existing literature that describe a plausible molecular pathway, but which do not themselves provide new experimental data. The PGC-1α → FNDC5 → irisin → BDNF cascade is supported by accumulating evidence from animal models and human studies, but the exact contribution of each pathway to the full exercise effect on human cognition and mood has not been resolved. Irisin is one of several candidate mediators, not a settled singular explanation.

The hippocampal neurogenesis findings in humans are more contested than those in animal models. Direct measurement of adult neurogenesis in living human brains is extremely difficult, and some studies using post-mortem tissue have raised questions about the extent to which robust hippocampal neurogenesis continues throughout adult life in humans at rates comparable to rodents. The Wang review (2026, Brain Sciences) largely examines the stroke context; extrapolation to healthy aging or exercise contexts involves additional assumptions.

The UK Biobank VILPA study provides the most direct evidence that movement — even brief, incidental movement — is associated with meaningful differences in brain health outcomes at population scale. But all the limitations of observational cohort research apply: confounding is never fully eliminated, the direction of causation is assumed but not demonstrated, and the hazard ratios describe average effects in a population that cannot be applied to any individual person.

The dose-response relationship between exercise and brain outcomes — how much, how often, what type, at what age — remains an open question. And the relative contributions of different mechanisms (irisin pathway, other myokines, cardiovascular effects, sleep quality improvements, reduced inflammation through other routes) have not been disentangled in humans.

What can be said with greater confidence is this: a molecular pathway connecting exercise, muscle-derived signaling, hippocampal BDNF, neurogenesis, and brain health outcomes now has enough evidence behind it that it is no longer speculative. The details of dose, timing, individual variability, and the relative importance of different mechanisms remain productive questions at the research frontier.